Finance

Lists
Q2 2026 earnings • released • EPS miss -171.19%
See results
SPTX:NASDAQ
Seaport Therapeutics Inc
$20.70
+0.22%
(+0.045) 1D
Aug 4, 9:50:15 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SPTX...
Open
$20.34
High
$21.20
Low
$20.34
Mkt. cap
1.11B
Avg. vol.
158.06K
Volume
1.67K
52-wk high
$23.00
52-wk low
$14.85
No. of employees
58
Open
$20.34
High
$21.20
Low
$20.34
Mkt. cap
1.11B
Avg. vol.
158.06K
Volume
1.67K
52-wk high
$23.00
52-wk low
$14.85
No. of employees
58
News stories
From sources across the web
About Seaport Therapeutics Inc
CEODaphne Zohar
Employees58
Founded2024
HeadquartersBoston, Massachusetts, United States
SectorPharmaceutical industry
Websiteseaporttx.com
Analyst ratings
Based on 6 analysts giving stock ratings to SPTX in the past 3 months
Strong buy
Buy
5
Hold
1
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for SPTX in the last 3 months.
Highest
Current $20.70
$50.00 (+141.60%)
Average
$38.40 (+85.55%)
Lowest
$30.00 (+44.96%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ram Selvaraju
H.C. Wainwright
Buy
Initiated
$50.00
+141.6%
07/15/2026
Rudy Li
Wolfe Research
Hold
Initiated
-
-
07/07/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
$30.00
+45%
06/09/2026
Tessa Romero
J.P. Morgan
Buy
Reiterated
$42.00
+102.9%
06/08/2026
Yigal Nochomovitz
Citi
Buy
Reiterated
$35.00
+69.1%
06/08/2026
Marc Goodman
Leerink Partners
Buy
Initiated
$35.00
+69.1%
05/27/2026
Last report
Aug 3, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
-$1.78 / -$0.66
-171.19%miss
Revenue / Est. (USD)
- / 0.00
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Mar 2026
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.53M
20.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
5.65M
6.11M
Operating expense
16.18M
26.98M
Total operating expenses
16.18M
26.98M
Operating income
-16.18M
-26.98M
Other non operating income
-9.00K
-46.00K
EBT including unusual items
-13.09M
-24.89M
EBT excluding unusual items
-13.09M
-24.89M
Income tax expense
31.00K
519.00K
Effective tax rate
-0.24%
-2.09%
Other operating expenses
-
-
Net income
-13.12M
-25.41M
Net profit margin
-
-
Earnings per share
-
-10.34
Interest and investment income
3.10M
2.13M
Interest expense
-
-
Net interest expenses
3.10M
2.13M
Depreciation and amortization charges
-
-
EBITDA
-16.15M
-26.95M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps